Canntab Therapeutics Limited
PILL
Rank in Stocks
#40491
Canntab Therapeutics Limited, a phytopharmaceutical firm with its main office... Canntab Therapeutics Limited, a phytopharmaceutical firm with its main office in Markham, Canada, is dedicated to the research and development of sophisticated, medical-grade cannabinoid compounds. The company's diverse portfolio within Canada includes various orally administered pharmaceutical cannabis products. These innovative dosage forms encompass extended-release cannabinoid pellets, rapid-onset cannabidiol options, multi-layered modified-release formulations, quickly dissolving flash-melt versions, and dual-layer cannabinoid tablets. Canntab's products are designed to address a wide spectrum of health concerns, such as sleep disturbances, post-traumatic stress disorder, social anxiety, different forms of addiction, arthritic conditions, general pain management, alleviating pain and stimulating appetite for cancer patients, and aiding in recovery from opioid and other painkiller dependencies.
Share Price
$0.0036163
Last synced: 2023-10-30
Market Cap
$118.21K
Change (1 day)
0.39%
Change (1 year)
3,516.30%
Country
CA
Trade Canntab Therapeutics Limited (PILL)
Category
Healthcare
Stock price history for Canntab Therapeutics Limited (PILL)
Highest end of day price: $0.00 on 2025-11-01
Lowest end of day price: $6.44 on 2017-11-01
Lowest end of day price: $6.44 on 2017-11-01
Stock price history of Canntab Therapeutics Limited from 2017 to 2026
Annual Stock Price Performance
| Year | Performance |
|---|---|
| 2026 (TTM) | 0.00% |
| 2025 | 0.00% |
| 2024 | -98.51% |
| 2023 | -50.94% |
| 2022 | -97.46% |
| 2021 | -12.65% |
| 2020 | 80.79% |
| 2019 | -53.66% |
| 2018 | -94.67% |
| 2017 | 0.00% |
Stock price for similar companies or competitors
| Company | Stock price | Change 1y% | Country |
|---|---|---|---|
| $171.67 | - |
DE
|
|
| $161.15 | 21.02% |
DE
|
|
| $41.46 | 47.41% |
JP
|
|
| $212.49 | 23.19% |
CH
|
|
| $19.19 | -0.09% |
IN
|
